Paper explores the challenges, opportunities and practical approaches when developing mathematical models to support policy decisions in newborn blood spot screening.
Analysis of UK NSC consultation responses published in journal article.
Newborn screening for hereditary tyrosinaemia type 1 (HT1) has been implemented in England.
The UK NSC’s Research and Methodology Group has advised on a wide range of screening research projects since its launch.
UK NSC is moving to a 2-yearly cycle for inviting stakeholders to submit new screening topic proposals.
The SMA screening ISE partnership board was updated on a range of activities at its most recent meeting.
The UK NSC has 15 vacancies to fill on 3 of its expert advisory groups.
The UK NSC evidence review process guidance has been updated with an expanded definition of in-service evaluation.
The UK NSC has published a suite of documents relating to the review of evidence on newborn screening for spinal muscular atrophy.
The UK National Screening Committee has opened a consultation on a recommendation to continue the in-service evaluation of newborn screening for SCID in NHS services.